Comparative Study between Residual Prostatic Tissue Size after Bipolar Vaporization of The Prostate versus Transurethral Resection of Prostate in Saline
Journal Title: The Egyptian Journal of Hospital Medicine - Year 2018, Vol 71, Issue 6
Abstract
<span>Objective: </span><span>To compare the outcomes of plasmakinetic vaporization of the prostate (PKVP) with transurethral resection of the prostate in saline (TURis), mainly residual prostatic tissue size after 3 months</span><span>.<br /> Materials and Methods: </span><span>In a randomized controlled trials, 30 patients with moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH) underwent PKVP (N = 15) and TURis (N = 15) between 2017-2018. </span><span>The inclusion criteria </span><span>were age between 40 and 80 who were indicated and scheduled for prostatectomy, prostate volume of 30-90 ml, serum prostate specific antigen (PSA) < 4 or free/total PSA </span><span><</span><span>0.25, if total PSA between 4 and 10, IPSS (The International Prostate Symptom </span><span>Score)≥ </span><span>20, </span><span>Qmax≤ </span><span>10 mL/s, and failed BPH-related medical therapy. </span><span>Exclusion criteria </span><span>were abnormal digital rectal exam (DRE) or ultrasonography with suspicion of prostate cancer, history of prostate cancer, bladder cancer, serum PSA < 10 ng/ml or free/total PSA ratio >0.25 if total PSA between 4 and 10, previous urethral or prostate surgery, urethral stricture, neurogenic bladder, bladder calculi, BPH-related hydronephrosis, preoperative hematuria due to any local or general cause, anticoagulant therapy or coagulation disorders. The perioperative and postoperative outcomes were evaluated and the residual prostatic tissue size, IPSS and Qmax were assessed preoperatively and 3 months after procedure in all cases. </span><span>Results: </span><span>Both groups were nearly similar in patient age, prostate volume, preoperative IPSS, Qmax, hospital stay and catheterization period. The PKVP group had significantly higher mean values of operative time, IPSS. Modified Clavien classification of complications was used to assess complications. No significant changes were seen between the two groups regarding complications (PKVP = 20%; TURis = 26.7%), no cases of TUR syndrome, obturator reflex, urethral stricture, clot retention or epididymitis occurred in both groups. In the transurethral resection in saline (TURis) group, 2 cases were presented by acute retention 2 weeks postoperative, only one case presented with mild to moderate dysuria 1 month post-operative, resolving with anti-inflammatory medication, mild hematuria was seen in 1 case 2 weeks postoperative. In plasma vaporization group, 1 patient had urinary retention which needed catheterization, urinary tract infection and significant bacteriuria occurred in one case which was treated by antibiotics and a mild to moderate dysuria after 1 month was seen in one case. Three months after surgery, two groups had significant improvement in IPSS (more in TURis group), post voiding volume, serum PSA, and mainly in residual prostatic tissue size.<br /> </span><span>Conclusions: </span><span>Bipolar electrosurgical technology is a promising modality for surgical treatment of BPH. Regarding bipolar prostatic surgeries we can conclude the following: No significant difference between bipolar plasma vaporization and TURis regarding residual prostatic tissue size, no TUR syndrome, less blood loss especially in vaporization technique, more easy learning curve either in vaporization technique or resection technique (no fear of TUR syndrome so time factor </span><span>isn’t </span><span>an issue) enabling the surgeon to work slowly and to do adequate hemostasis, vaporization technique is ideal modality for high risk patients (multiple co morbidities, bleeding tendency and patient on anticoagulants). Large prostate volume can be treated either by resection or vaporization technique). We can conclude that the bipolar plasmakinetic energy will be the gold standard in surgical management of BPH in the near future if it not yet.<br /> </span>
Authors and Affiliations
Eman Helal
Keywords
Related Articles
- EP ID EP583988
- DOI -
- Views 99
- Downloads 0
Correlation between Clinical and Urodynamic Improvement in Patients with Overactive Bladder Syndrome on Anticholinergic Drugs
<strong>Background:</strong> The International Continence Society (ICS) defined overactive bladder syndrome (OAB) as urinary urgency with or without urge incontinence, often accompanied by frequency and nocturia in absen...
Monitoring of Free Living Amoeba in Some Drinking Water Treatment Plant in Great Cairo Governorate, Egypt
<span>Background: </span><span>Free-living amoebae (FLAs) in drinking water exerts an indirect public health hazards as they may harbor pathogenic microorganisms that can escape drinking water treatment processes and rea...
Knowledge and Awareness of Diabetic Foot Complications in Diabetic Patients
<strong>Background: </strong>diabetic foot problems are common throughout the world, resulting in major economic consequences for the patients, their families, and society. Foot ulcers are more likely to be of neuropathi...
Interbody Fusion. Is It Has a Rule in Broken Screws in Surgical Management of Lumbar Spondylolisthesis?
<span>Background: </span><span>for many years, posterolateral fixation for lumbar spondylolisthesis by using pedicle screw has been the standard procedure for lumbar spondylolisthesis. For increasing fusion and anterior...
Stem Cell Therapy in Glaucoma
Glaucoma is a chronic, degenerative optic neuropathy, which cause progressive damage to the optic nerve, retinal ganglion cell (RGC) death and characteristic damage to the visual field. Current glaucoma therapeutics lowe...